Biotech News
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
ir.anaptysbio.com2026-05-06 14:57 EST
SAN DIEGO , Jan. 06, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga , president and chief executive officer of Anaptys, will present at the 44 th Annual J.P.